BRIEF—Samsung continues to add bio-manufacturing capacity

Contract development and manufacturing organization (CDMO) Samsung Biologics has commenced operations at Plant 4, part of the world’s largest bio-manufacturing plant.

The powering up of the facility at the company’s Bio Campus I location comes around two years after construction began. The additional capacity will help the firm boost operational efficiency and meet growing demand.

When Plant 4 is fully operational, Samsung Biologics will have a total capacity of 604,000 liters at Bio Campus I.

The company has also acquired additional land for Bio Campus II, which will host four further plants and a center for innovation. Construction on that work is slated to begin in late 2022.